Publications
305 publications
Sort by: Date / Relevance
Hydroquinine (Inhibin®) for patients with nocturnal muscle cramps
Zorginstituut Nederland has assessed whether hydroquinine (Inhibin®) should be included in the medication reimbursement system ...
Voretigene neparvovec (Luxturna®) for the treatment of vision loss due to inherited retinal dystrophy with bi-allelic RPE65 mutations
Zorginstituut Nederland has completed its assessment whether voretigene neparvovec (Luxturna®) for the treatment of vision loss ...
Emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in patients with severe haemophilia A without inhibitors
Zorginstituut Nederland has completed its assessment whether emicizumab (Hemlibra®) for the prophylactic treatment of bleeding in ...
GVS assessment of racecadotril (Hidrasec®) for the treatment of acute diarrhoea in infants (over 3 months of age) and children
The Zorginstituut has completed its assessment whether racecadotril (Hidrasec®) is interchangeable with another product that is ...
GVS assessment of a 4 component meningococcal B vaccine (Bexsero®)
Zorginstituut Nederland has completed its assessment whether the product 4 component meningococcal B vaccine (4CMenB) (Bexsero®) ...
Metreleptin (Myalepta®) for treatment of lipodystrophy
Zorginstituut Nederland has completed its assessment whether metreleptin (Myalepta®) for treatment of lipodystrophy can be ...
GVS assessment of extension of further conditions for GLP-1ra
The minister for Medical Care asked Zorginstituut Nederland to extend the further conditions for the glucagon-like peptide 1 ...
Ciclosporin (Ikervis®) for the treatment of severe keratitis in adult patients with the dry eye syndrome
Zorginstituut Nederland has completed its assessment whether ciclosporin (Ikervis®) for the treatment of severe keratitis in ...
Dabrafenib/trametinib (Tafinlar®/Mekinist®) for the adjuvant treatment of adult patients with stage III melanoma
Zorginstituut Nederland has completed its assessment of dabrafenib (Tafinlar®) in combination with trametinib (Mekinist®) for the ...
GVS assessment of fampridine (Fampyra®) for use in a subgroup of MS patients
Zorginstituut Nederland has completed its assessment whether fampridine (Fampyra®) can be included in the Medication ...